These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 827414)

  • 1. [Re-evaluation of the action of salicylate on glucose and insulin blood levels in normal and diabetic subjects and possible interference with oral antidiabetic therapy].
    Pitucco G; Santucci A; Caputo V; De Mattia G; Federico M
    Clin Ter; 1976 Aug; 78(3):227-44. PubMed ID: 827414
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 4. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
    Pitucco G; Caputo V; Santucci A; Daniele E; De Mattia G; De Angelis A
    Clin Ter; 1978 Jun; 85(6):550-8. PubMed ID: 97042
    [No Abstract]   [Full Text] [Related]  

  • 6. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled clinical study of the therapeutic action of 2 combinations of glibenclamide and phenformin].
    Mascetti P; Mascetti R; Sampietro M
    Clin Ter; 1978 Aug; 86(3):263-75. PubMed ID: 105830
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats.
    Pari L; Saravanan R
    Diabetes Obes Metab; 2004 Jul; 6(4):286-92. PubMed ID: 15171753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
    Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
    Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 14. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR; Wragg KG; Shetty KT; Biggs PI; Davies CD
    Horm Metab Res; 1979 Jun; 11(6):411-2. PubMed ID: 112018
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide.
    Lee PE; Meneilly GS
    Diabetes Metab; 1999 Sep; 25(4):347-9. PubMed ID: 10566126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined intravenous glucose-glibenclamide load as test for prediction of success of oral longtime therapy of adult diabetes with glibenclamide].
    Raptis S; Schröder KE; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1973; 79():1210-3. PubMed ID: 4208214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the new Hungarian glibenclamide product (Gilemal)].
    Béla P; Miklós G
    Orv Hetil; 1976 Nov; 117(46):2792-4. PubMed ID: 824601
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavior of serum insulin in the double intravenous glucose tolerance test in diabetics before and during glibenclamide therapy].
    Niklas L; Wiederhold K; Otto H
    Verh Dtsch Ges Inn Med; 1971; 77():546-50. PubMed ID: 5005530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.